Steady-state pharmacokinetics of once-daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers*-Reference-Cited by-同舟云学术

Steady-state pharmacokinetics of once-daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers*

Published:2007-08-23 Issue:7 Volume:8 Page:457-464
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:

Author:

Luber AD,Brower R,Kim D,Silverman R,Peloquin CA,Frank I

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1293.2007.00496.x/fullpdf

Reference22 articles.

1. Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy;Dieleman;The ATHENA Cohort. AIDS,2002

2. Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort;O'Brien;J Acquir Immune Defic Syndr,2003

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B/F/TAF forgiveness to non-adherence;Sexually Transmitted Infections;2024-07-04

2. Profile of drug–drug interactions and impact on the effectiveness of antiretroviral therapy among patients living with HIV followed at an Infectious Diseases Referral Center in Belo Horizonte, Brazil;The Brazilian Journal of Infectious Diseases;2020-03

3. Quantification of fosamprenavir in spiked human plasma using liquid chromatography-electrospray ionization-tandem mass spectrophotometry-application to pharmacokinetic study;EGYPT PHARM J;2019

4. Design strategies in the prodrugs of HIV-1 protease inhibitors to improve the pharmaceutical properties;European Journal of Medicinal Chemistry;2017-10

5. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus;Drugs;2017-02-23